Vascular Magnetics
Stage
Series A | AliveTotal Raised
$7MLast Raised
$7M | 11 yrs agoAbout Vascular Magnetics
Vascular Magnetics is developing therapeutic products based on the magnetic targeting of drug-loaded biodegradable particles. The company's first product in development is a treatment for peripheral artery disease that is designed to target anti-restenotic drugs specifically to diseased arterial sites and deliver doses not achievable with a drug eluting stent. The company's approach, called Vascular Magnetic Intervention (VMI), combines a magnetic targeting catheter, and external magnetic device, along with drug-loaded biodegradable particles. Peripheral artery disease is a growing chronic condition characterized by obstruction of the arteries in the legs. Intermittent claudication (crippling leg pain) is the most common and debilitating symptom of PAD. PAD can progress to compromise the blood supply to the affected leg, resulting in diminished function and quality of life, gangrene and subsequent amputation. All PAD patients have a higher risk of strokes and heart attacks. Risk factors for the condition include diabetes, elevated cholesterol, and hypertension. Current treatments, including angioplasty, grafts, stents and drug eluting stents are not particularly effective, with restenosis occurring at an annual rate of 20-40 percent. PAD-related costs, including amputation and amputation-related deaths, are estimated at up to $290 billion per year in the US alone.
Missing: Vascular Magnetics's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Vascular Magnetics's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Vascular Magnetics
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Vascular Magnetics is included in 1 Expert Collection, including Diabetes.
Diabetes
1,903 items
Latest Vascular Magnetics News
Jan 4, 2013
Vascular Magnetics (Philadelphia, PA) a development-stage medical device focused on magnetically targeted drug delivery for the treatment of peripheral artery disease, closed a $7M Series A financing. Note: Closing out 1Q deals. Thanx for your patience as we play catch-up. Welcome to Where Ever you Are 1 Venture Capital Investors
Vascular Magnetics Frequently Asked Questions (FAQ)
Where is Vascular Magnetics's headquarters?
Vascular Magnetics's headquarters is located at 3711 Market Street, Philadelphia.
What is Vascular Magnetics's latest funding round?
Vascular Magnetics's latest funding round is Series A.
How much did Vascular Magnetics raise?
Vascular Magnetics raised a total of $7M.
Who are the investors of Vascular Magnetics?
Investors of Vascular Magnetics include Devon Park Bioventures.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.